TickerFactsScreenerDevelopers

XBiotech Inc. (XBIT) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $4.17M2013: $7.24M2014: $57.33M2015: $91.05M2016: $34.32M2017: $31.77M2018: $15.82M2019: $714.59M2020: $237.37M2021: $236.98M2022: $157.31M2023: $200.02M2024: $172.68M2025: $125.55M$125.55M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$125.55M-27.3%
2024$172.68M-13.7%
2023$200.02M+27.2%
2022$157.31M-33.6%
2021$236.98M-0.2%
2020$237.37M-66.8%
2019$714.59M+4416.2%
2018$15.82M-50.2%
2017$31.77M-7.4%
2016$34.32M-62.3%
2015$91.05M+58.8%
2014$57.33M+691.4%
2013$7.24M+73.8%
2012$4.17M—